<DOC>
	<DOCNO>NCT02002754</DOCNO>
	<brief_summary>This study aim observe response Bambuterol Hydrochloride tablets treatment subject eosinophilic bronchitis . The investigator hypothesize : A subject EB responses Bambuterol Hydrochloride tablets therapy . Most subject CVA respond well Bambuterol Hydrochloride tablets therapy</brief_summary>
	<brief_title>The Effect Bronchodilator Eosinophilic Bronchitis Cough Variant Asthma</brief_title>
	<detailed_description>Study group : 45 patient chronic cough collect two group form base diagnosis follow : Group 1 : EB group The patient eosinophilic bronchitis receive Bambuterol Hydrochloride tablets 10mg Q24 three day . Group 2 : CVA group The patient cough variant asthma receive Bambuterol Hydrochloride tablets 10mg Q24 three day . Observe response Bambuterol Hydrochloride tablet treatment three day later compare effective rate patient EB CVA . Then study .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Cough</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Bambuterol</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<criteria>1 . Patients history cough sole main symptom last 8 week . 2 . Patients whose chest xray outcome normal without active focus . 3 . Patients eosinophilic bronchitis diagnose result sputum eosinophil percentage ( Eos % ) 2.5 % , negative result bronchial provocation test methacholine inhalation challenge . 4 . Patients cough variant asthma positive result bronchial provocation test . 5 . Patients age 18 year old ( ≥ 18 year old ) 75 year old ( ≤ 75 year old ) . 1 . Patients smoker exsmoker smoke within previous year cumulative smoking history ＞10 packyears equivalence . 2 . Patients concomitance GERC ( gastroesophageal refluxrelated chronic cough ) , chronic bronchitis , bronchiectasis , bronchial tuberculosis , ACEI induce cough , bronchogenic carcinoma , psychologic cough , pulmonary fibrosis , bronchus foreign body , microlithiasis , tracheobroncheopathia osteochondroplastica , mediastinal tumor , leave ventricular dysfunction . 3 . Female subject pregnant , breastfeed risk become pregnant study . 4 . Subjects diagnose past present disease , judge investigator , may affect outcome study . These disease include , limited , cardiovascular disease , malignancy , hepatic disease , renal disease , haematological disease , neurological disease , endocrine disease pulmonary disease . e.g.nasalsinus infection , low respiratory tract infection , chronic bronchitis , emphysema , bronchiectasis , cystic fibrosis bronchopulmonary dysplasia . 5 . Subjects demonstrate significant abnormality biochemistry , hematology , ECG . 6 . Patients cooperate u .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>eosinophilic bronchitis</keyword>
	<keyword>cough variant asthma</keyword>
	<keyword>bronchodilator</keyword>
</DOC>